mRNA Opportunities: Lessons Learned, Priorities, and the Future of GCT
Monday, May 2, 2022
Dr. Bourla will share what Pfizer has learned from its leadership on mRNA and the development of the Covid vaccine that can be extrapolated to other R&D.
- Moderator:
- Panelist:
